A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Losartan Impurity 34 | CAS 158365-99-2 - Request Quote

Picture of Losartan Impurity 34

Losartan Impurity 34

SZ CAT No:SZ-L028072
CAS No
158365-99-2
Mol.F.
C7H11ClN2
Mol.Wt.
158.6
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Losartan Impurity 34 is chemically 2-Butyl-5-chloro-1H-imidazole. Losartan Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Losartan Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Losartan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 158365-99-2

Purchase 158365-99-2

Order 158365-99-2

Enquire 158365-99-2

price of 158365-99-2

158365-99-2 Supplier

158365-99-2 Manufacturer

158365-99-2 Exporter

buy high quality Losartan Impurity 34

Purchase Losartan Impurity 34

Losartan Impurity 34 suppliers

Losartan Impurity 34 manufacturers

Losartan Impurity 34 price

Order Losartan Impurity 34

Enquire Losartan Impurity 34

Losartan Impurity 34 cost

Losartan Impurity 34 Supplier

Losartan Impurity 34 Distributor

Losartan Impurity 34 for Method Validation

Losartan Reference Standard

Losartan Impurity 34 for ANDA Filing

Losartan Impurity 34 for Forced Degradation Studies

Losartan Impurity 34 Identification Standards

Losartan Impurity 34 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,